Review for 10.1186/s12876-021-01702-y (2021)

Reviewer’s report
Title: 
Fibromuscular dysplasia of mesenteric arteries – a rare cause of multiple bowel resections: A case
report and literature review
Version: 
1 
Date: 
16 Feb 2021
Reviewer's report:
Revision is clearer although there remain a few issues which would be recommended for revision to
ensure clarity and flow of the article:
Line 24 - "In her thirty fourth,.." - this should be "At the age of 34 years"
Line 26 - "She was considered likely down with CD" - I assume this is trying to say "a clinical diagnosis of
presumed CD was made"
Line 37 -"In addition, symptoms and endoscopic manifestations partly similar to CD and BD" - would be
better worded as "In addition, symptoms and endoscopic manifestations may appear similar to CD and
BD"
Line 52 "To date, there are few literatures have been reported on this condition…" should be either limited
literature of few cases
Line 58 - Tumography should be tomography
Line 75 - erythrocytes is not needed as haemoglobin will suffice
Line 86 - "Due to atypical clinical symptoms and examination results, a diagnosis of CD was considered,
but a diagnosis of BD still needed to be excluded" - this would read better as "Due to atypical clinical
symptoms and examination results, a diagnosis of CD was felt most likely, although BD could not be
excluded"
Line 87 - has to was
Line 97 - "no longer treated with steroid and antiplatelet." - Anti platelet medication is not mentioned
previously - this needs to be added if patient was using. This may be better stated as steroid medication
was ceased.
Line 103 - remove capitalisation of Due
Line 104 - suggest refused should be changed to declined 
Line 104 - the reason splenectomy was recommended (cytopenias) should be added
Line 120 - "changed or not" - better phrased as variably affected
Line 128 - suggest refused should be changed to declined
Line 136 - "in some part ways" should be either 'in part' or 'in some ways'
Line 139 - elder to older patient
Publons Reviewer Recognition
. Springer Nature can send verification of this review directly to Publons
(a subsidiary of Clarivate Analytics). If you would like to take advantage of this service, please click on
the “Yes” option below. Your name, email address, title of the reviewed manuscript, name of the journal,
and date of your review submission (the “Review Data”) will then be transmitted to Publons after the final
decision on the manuscript has been made. If you have already registered at Publons, they will notify you
of the receipt of this review and update your profile 
as per your settings and their policy. If you are not
registered with Publons, you will receive an email from them asking you to register in order for them to
be able to recognize your review on your new profile page. Publons may use the Review Data to generate
derivative metadata for the benefit of Publons and you as a reviewer, carefully considering the sensitivity
of such information. For example, Publons may verify your record as a reviewer by updating your profile
published on its webservice if you have registered for such service or help editors to identify candidate
reviewers. Please find the details of processing in Publons’ privacy policy
https://publons.com/about/terms
Yes
Declaration of competing interests
Please complete a declaration of competing interests, considering the following questions:
1
. 
Have you in the past five years received reimbursements, fees, funding, or salary from an
organisation that may in any way gain or lose financially from the publication of this manuscript,
either now or in the future?
2
. 
Do you hold any stocks or shares in an organisation that may in any way gain or lose financially
from the publication of this manuscript, either now or in the future?
3
. 
Do you hold or are you currently applying for any patents relating to the content of the manuscript?
4
. 
Have you received reimbursements, fees, funding, or salary from an organization that holds or has
applied for patents relating to the content of the manuscript?
5
. 
Do you have any other financial competing interests?
6
. 
Do you have any non-financial competing interests in relation to this paper?
If you can answer no to all of the above, write 'I declare that I have no competing interests' below. If your
reply is yes to any, please give details below.
I declare that I have no competing interests
Reviewer Publication Consent.
 I agree for my report to be made available under an Open Access
Creative Commons CC-BY License (
 http://creativecommons.org/licenses/by/4.0
) if this manuscript is
accepted for publication. Any comments that I do not wish to be included in the published report have
been included as confidential comments to the editor, which will not be published.
If you are not happy for us to publish this report, please contact the editorial office before completing
the review.
If you wish, you can include your name in your published report. Please note you must decide whether
to include your name at the start of the process and confirm this decision whenever prompted. If you
change your decision later, we will not be able to publish your name.
I agree to the terms of the CC-BY 4.0 license; please 
do not
 publish my name with my report. (default)
Is the study design appropriate to answer the research question (including the use of appropriate controls),
and are the conclusions supported by the evidence presented?
Yes
Are the methods sufficiently described to allow the study to be repeated?
Yes
Is the use of statistics and treatment of uncertainties appropriate?
Yes
Is the presentation of the work clear?
Yes
Are the images in this manuscript (including electrophoretic gels and blots) free from apparent
manipulation?
Yes